Immutable, Open Ledgers To Be A Welcome Change To The Phenylketonuria Treatment

Posted by Steve Sharma on May 17th, 2022

Phenylketonuria Treatment Market is all set to unleash its potential to the fullest, at a CAGR of 7%. The new normal constitutes video chatting with therapists. The patients are thus able to create their profile and look for the therapist (s) of their choice. Patients could, thus share the data from various apps and share it with their provider (s) for a better understanding of the personalized care needed by them. Such would be the healthcare vertical.

Phenylketonuria (PKU) is an inherited disorder caused by excess of phenylalanine in the blood, which can lead to severe intellectual disabilities. There is no cure for phenylketonuria as yet, and dietary management is the only option to maintain the phenylalanine level in the body. Untreated infants with PKU tend to have unusually light eye, skin, and hair colour due to excess of phenylalanine levels interfering with melanin. Neurological symptoms such as seizures, abnormal muscle movement, tremors, or involuntary movement are some of the symptoms mainly observed in such patients.

Get Free Sample Copy of this Report@ https://www.persistencemarketresearch.com/samples/14410

Like it? Share it!


Steve Sharma

About the Author

Steve Sharma
Joined: April 12th, 2021
Articles Posted: 447

More by this author